Retraction: Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway
- 1Department of Oncology, The First Affiliated Hospital of Jinan University, Guangzhou, China
- 2Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China
- 3Department of Traditional Chinese Medicine, Cancer Center of Sun Yat-sen University, Guangzhou, China
- 4Department of Traditional Chinese Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China
Citation: Wu L-M, Liao X-Z, Zhang Y, He Z-R, Nie S-Q, Ke B, Shi L, Zhao J-F and Chen W-H (2021) Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway. Front. Cell Dev. Biol. 8:610097. doi: 10.3389/fcell.2020.610097
Received: 25 September 2020; Accepted: 30 November 2020;
Published: 05 February 2021; Retracted: 05 May 2021.
Edited by:
Inna N. Lavrik, University Hospital Magdeburg, GermanyReviewed by:
Jiaxing Zhang, Sun Yat-sen University, ChinaMario Cioce, Campus Bio-Medico University, Italy